NHS Framework Agreement for Branded Medicines - National
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,478,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 17 Jan 2019 |
| Contract start | 1 May 2019 |
| Contract end | 30 Apr 2021 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7 |
Awards (73)
This procurement was awarded to 73 suppliers. Values shown are per-award; the notice total is £1,478,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Accord-UK ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Acre Pharma Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aguettant Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Alliance Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| ALMIRALL LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aspen Pharma Ireland Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aspire Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| AstraZeneca UK LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Aventis Pharma Ltd trading as Sanofi shared | £1,351,341,890 | 30 Apr 2019 | active |
| Bayer Plc shared | £1,351,341,890 | 30 Apr 2019 | active |
| B. Braun Medical Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Beaver Visitec International Sales Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Biofrontera Pharma GmbH shared | £1,351,341,890 | 30 Apr 2019 | active |
| Biogen Idec UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Bristol-Myers Squibb Pharmaceuticals Ltd. shared | £1,351,341,890 | 30 Apr 2019 | active |
| CCMed Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Chiesi Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Cipla (EU) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Consilient Health shared | £1,351,341,890 | 30 Apr 2019 | active |
| Crescent Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Desitin Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Dexcel Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Dr Falk Pharma UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| DRUGSRUS LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Eisai Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| ELI LILLY & COMPANY LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ennogen Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ferndale Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ferring Pharmaceutical shared | £1,351,341,890 | 30 Apr 2019 | active |
| Flynn Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Focus Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Gedeon Richter (UK) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Generics [UK] ta Mylan shared | £1,351,341,890 | 30 Apr 2019 | active |
| Genzyme Therapeutics Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Gilead Sciences shared | £1,351,341,890 | 30 Apr 2019 | active |
| GlaxoSmithKline UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Glenmark Pharmaceuticals Europe shared | £1,351,341,890 | 30 Apr 2019 | active |
| Intrapharm Laboratories Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Ipsen Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Janssen-Cilag Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Kent Pharmaceuticals LTD shared | £1,351,341,890 | 30 Apr 2019 | active |
| Kyowa Kirin Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Lupin Healthcare (UK) Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Macarthys Laboratories t/a Martindale Pharma shared | £1,351,341,890 | 30 Apr 2019 | active |
| medac Pharma LLP shared | £1,351,341,890 | 30 Apr 2019 | active |
| Merck shared | £1,351,341,890 | 30 Apr 2019 | active |
| Mercury Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Morningside Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Napp Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Neon Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Nordic Pharma Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Norgine Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Novartis Pharmaceuticals UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Novo Nordisk Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| ParaPharm Development Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Pfizer Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Pharmacosmos UK Ltd. shared | £1,351,341,890 | 30 Apr 2019 | active |
| Rayner Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| RB UK Healthcare Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Roche Products Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Rosemont Pharmaceuticals Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
| Sandoz Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| SELECTIVE SUPPLIES LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Takeda UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| TEVA UK LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Thea Pharmaceuticals Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| TILLOMED LABORATORIES LIMITED shared | £1,351,341,890 | 30 Apr 2019 | active |
| Tillotts Pharma UK Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Torrent Pharma (UK) Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Typharm Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| UCB Pharm Ltd shared | £1,351,341,890 | 30 Apr 2019 | active |
| Zentiva Pharma UK Limited shared | £1,351,341,890 | 30 Apr 2019 | active |
description
NHS Framework Agreement for Branded Medicines - National
Contract Period: 1 May 2019 to 30 April 2021 (with an option to extend for a period or periods of up 24 months)
Tender Reference: CM/PHR/16/5518
documents
- https://nhsengland.bravosolution.co.uk , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/67c3adb8-8e54-497c-8e30-1ebb107d4d85 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/037bfc3c-6794-4098-b289-12789e502985 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2cb2a084-3613-44cf-9c26-c36466223da3 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/570b0e43-9744-4e97-977b-3b3032aa7449 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/7fd2f8f3-59a9-4046-80fa-7f291545f3b2 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8eea26ec-d94e-4418-8a36-62456618cb26 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/af313fee-a604-46e3-a6ee-7524e9e9cb1c , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/af651003-04b3-43f1-8005-cab7e29fde6c , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/bc26550b-3940-4766-a449-8ab3e22b50d3 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c4afd279-50b5-4502-a181-0711b947be28 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ccf7efb6-1f8f-4237-85bc-71d280783200 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d0d5c13c-f19f-4886-92f7-f0583a7d0506 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d699efd2-36fc-49c5-aa37-f4f8adf85d49 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/dea9f737-ed9b-4741-b375-8a49e2643646 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ea26850f-aeac-491b-b541-5fb984137ab0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 13 Dec 2018 | Tender (tender) | · | 67c3adb8-8e54-497c-8e30-1ebb107d4d85-258849 |
| 9 Aug 2019 | Award update (awardUpdate) | · | 166b70b9-418c-40ef-9712-5c4939822674-306787 |
more from NHS England
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.